SynopsisThe global Bioartificial Renal Assist Devices market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Bioartificial Renal Assist Devices vol.....
SynopsisThe RF hyperthermia machine is a non-contact treatment method, using radio frequency waves to heat the tissue to a temperature that can kill tumor cells, and the duration is 60-120 minutes, which can kill tumor cells without damaging normal tissues. Purpose.
SynopsisAtrial septal defect (ASD) is one of the most common congenital heart defects requiring procedural intervention. ASD closure devices are intended to close openings between the atria (the two upper chambers of the heart). It can be used to treat patients with c.....
SynopsisSurgical apparel is used to provide optimal level of protection by reducing the transfer of bacteria from the skin to the surgical staff. The global Surgical Apparel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030.....
SynopsisThe global Abdominal Aorta Stent Graft System market was valued at US$ 3202.6 million in 2023 and is anticipated to reach US$ 4006.9 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. North American market for Abdominal Aort.....
SynopsisThe global Sickle Cell Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, .....
SynopsisImplantable Blood Glucose Monitor is implanted subcutaneously into the upper arm under local anesthesia, the system allows for replacement of finger stick blood glucose measures. The global Implantable Blood Glucose Monitor market was valued at US$ 39 mi.....
SynopsisUrokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from h.....
SynopsisPalonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). The global Palonosetron market was valued at US$ 113 million in 2023 and is anticipated to reach US$ 147.6.....
SynopsisThe global Alzheimer’s Agitation Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022.....
